东方证券研报指出，从具象到抽象，润丰股份的壁垒在不断加强，体现在登记布局、商业化能力、团队建设三个方面。登记布局上，公司基于终端市场的产品组合需求进行前瞻布局，数量级领先；国内企业出海主要围绕自产原药大单品布局，且优先拉美、东南亚等地区，而公司巴西登记证存量和增量都遥遥领先，且已经布局了欧美等更高壁垒市场。商业化上，公司已进入出海深水区，聚焦高难度但高利润率区域、模式和产品结构的商业化进程，进一步拉开与同行的差距。团队养成上，壁垒最抽象也最难以复制，公司形成了中外搭配的国际化阵容，尤其是沉淀了一支迎难而上的长期驻外深耕团队，背后是公司企业家精神自上而下的表达。纸上得来终觉浅，绝知此事要躬行，当我们还在纠结该不该出海，从哪里出海，出海走多远的时候，公司已经在出海硬件和软件的支撑上进行了多轮迭代，壁垒不断稳固加强。给予可比公司25年20倍PE，对应目标价82.00元，维持“买入”评级。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.